Patient Guide: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07024641
Status: 🟢 Enrolling Now
Condition: Infections, Communicable Diseases, Hepatitis A, Virus Diseases, Hepatitis B, Hepatitis B, Chronic, Herpesviridae Infections, Hepatitis
Phase: PHASE1

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Chandler, Arizona
  • • Huntington Beach, California
  • • Lake Forest, California
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection - Join Clinical Trial NCTNCT07024641

How to Join This Clinical Trial - NCTNCT07024641

Learn how to participate in this PHASE1 trial studying an investigational therapy for Infections, Communicable Diseases, Hepatitis A, Virus Diseases, Hepatitis B, Hepatitis B, Chronic, Herpesviridae Infections, Hepatitis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Infections, Communicable Diseases, Hepatitis A, Virus Diseases, Hepatitis B, Hepatitis B, Chronic, Herpesviridae Infections, Hepatitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Infections, Communicable Diseases, Hepatitis A, Virus Diseases, Hepatitis B, Hepatitis B, Chronic, Herpesviridae Infections, Hepatitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07024641 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Chandler, Arizona 85225 - United States

Status: RECRUITING

Clinical Research Site

Huntington Beach, California 92647 - United States

Status: RECRUITING

Clinical Research Site

Lake Forest, California 92630 - United States

Status: RECRUITING

Clinical Research Site

Long Beach, California 90805 - United States

Status: RECRUITING

Clinical Research Site

Peachtree Corners, Georgia 30071 - United States

Status: RECRUITING

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78215 - United States

Status: RECRUITING

Clinical Research Site

Webster, Texas 77598 - United States

Status: RECRUITING

Clinical Research Site

Richmond, Virginia 23284 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Infections, Communicable Diseases, Hepatitis A, Virus Diseases, Hepatitis B, Hepatitis B, Chronic, Herpesviridae Infections, Hepatitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships